KRTL Boosts Bolivian Company’s Entry Into U.S. Pharma Market

Lakewood-based KRTL Holding Group Inc. (OTC: KRTL) announced that its subsidiary, KRTL Biotech Inc., has successfully registered Industria Químico Farmaceutica SIGMA CORP. S.R.L. (SIGMACORP) with the U.S. Food and Drug Administration (FDA) as a U.S. pharmaceutical manufacturer. As the U.S. Registered Agent for SIGMACORP, KRTL Biotech is facilitating international pharmaceutical integration and diversifying the U.S….

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here